Which patients with gynaecomastia require more detailed investigation?
File(s)
Author(s)
Ali, SN
Jayasena, CN
Sam, AH
Type
Journal Article
Abstract
Gynaecomastia may be due to medication, chronic liver or kidney disease, hypogonadism (primary or secondary to pituitary disease) or hyperthyroidism. Having excluded these aetiologies, it is imperative to be vigilant for underlying malignancy causing gynaecomastia. These include human chorionic gonadotrophin‐secreting testicular and extratesticular tumours and oestrogen‐secreting testicular tumours and feminising adrenal tumours.
Date Issued
2018-03-01
Date Acceptance
2017-11-27
Citation
CLINICAL ENDOCRINOLOGY, 2018, 88 (3), pp.360-363
ISSN
0300-0664
Publisher
WILEY
Start Page
360
End Page
363
Journal / Book Title
CLINICAL ENDOCRINOLOGY
Volume
88
Issue
3
Copyright Statement
© 2017 John Wiley & Sons Ltd. This is the accepted version of the following article: Ali SN, Jayasena CN, Sam AH. Which patients with gynaecomastia require more detailed investigation?. Clin Endocrinol (Oxf). 2018;88:360–363. https://doi.org/10.1111/cen.13526
Sponsor
National Institute for Health Research
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000425138800002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Grant Number
PDF-2017-10-098
Subjects
Science & Technology
Life Sciences & Biomedicine
Endocrinology & Metabolism
gynaecomastia
human chorionic gonadotrophin
malignancy
oestrogen
LEYDIG-CELL TUMOR
OF-THE-LITERATURE
ADRENOCORTICAL CARCINOMA
CHORIONIC-GONADOTROPIN
TESTICULAR CANCER
TESTIS
FEATURES
RECEPTORS
ESTRADIOL
ESTRONE
Publication Status
Published
Date Publish Online
2017-12-21